Latest Breaking News On - Tracer aav capsids - Page 1 : vimarsana.com

Under the terms of the agreement, Pfizer will have the right to evaluate novel capsids selected for central nervous system and cardiac tropisms from Voyager s TRACER platform and to exercise options.

United statesTseng chengMichael higginsPfizer rare disease research unitMeeting of the american society geneTropism redirectionCell type specific expressionSenior vice presidentChief scientific officerRare disease researchAnnual meetingAmerican societyCell therapyTracer platformVoyager therapeuticsGene therapy